Cephalandra Indica Q in Diabetes Mellitus type-2

Exploring the therapeutic potential of Cephalandra Indica Q in the management of Diabetes Mellitus Type-2. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070925

Enrollment

Registered

2024-07-19

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Cephalandra Indica Q: Cephalandra Indica Q. Dose- As mother tincture form Frequency- twice a day and as per required/ susceptibility of patient Route of administration- Oral (Sublingua

Eligibility

Inclusion criteria

Inclusion criteria: 1. Samples of both sexes, aged from 30 to 60 will be taken. 2. Patients of all the socio-economic status. 3. Diagnosed with diagnostic criteria of Diabetes Mellitus confirmed with blood investigation. 4. Patient willing to give consent. 5. Cases of Type-2 Diabetes Mellitus with HbA1c levels 6.5-9%.

Exclusion criteria

Exclusion criteria: 1. Patients with IDDM. 2. Pregnant and Lactating women. 3. Patients who are critically ill and with severe complications of diabetes and bedridden patients. 4. Life-threating complications and require hospitalization.

Design outcomes

Primary

Measure	Time frame
Assessment of Diabetes Mellitus with blood investigation- FBS & PP2BS every monthTimepoint: 15days, 30days	—

Secondary

Measure	Time frame
Assessment of Diabetes Mellitus with blood investigation- HbA1C before & after studyTimepoint: 6 months	—

Countries

India

Contacts

Public ContactDr Kruti V Sanghani

Jawaharlal Nehru Homoeopathic Medical College

krishna.raj93649@paruluniversity.ac.in7383869199

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026